Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products... Show more
LFVN is expected to report earnings to rise 23.53% to 20 cents per share on October 29
Q3'25
Est.
$0.21
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.06
Q4'24
Beat
by $0.08
Q3'24
Missed
by $0.02
The last earnings report on September 04 showed earnings per share of 17 cents, beating the estimate of 15 cents. With 473.68K shares outstanding, the current market capitalization sits at 152.44M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LFVN showed earnings on September 04, 2025. You can read more about the earnings report here.